William D. Waddill, Director: Arrowhead Pharmaceuticals ARWR Sell · Filed 25/12/23

Trade details

Type: Insider sale
Amount: $370,722.51
Shares · price: 5,451 sh · $68.01 a share
Held after: 57,063 sh
Stock: Arrowhead Pharmaceuticals ARWR
Person: William D. WaddillDirector
Trade date: 25/12/19
Filed: 25/12/23
Days to filing: 4 days

Sold 8.7% of holdings

Share of holding sold: 8.7%

Arrowhead Pharmaceuticals trades, last 26 weeks

What else happened in Arrowhead Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/11/19~01/18

William D. Waddill's recent trades

William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$1.1M
9,000 sh
$1.1M
Filed 06/25
Traded 06/23
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$1M
9,000 sh
$1M
Filed 06/23
Traded 06/23
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$969.1K
9,000 sh
$969.1K
Filed 06/11
Traded 06/10
William D. WaddillDirector
Planned sale10b5-1 planProtagonist Therapeutics
Planned sale10b5-1 plan
Protagonist Therapeutics
PTGX
$952.8K
9,000 sh
$952.8K
Filed 06/10
Traded 06/10
William D. WaddillDirector
Sell10b5-1 planProtagonist Therapeutics
Sell10b5-1 plan
Protagonist Therapeutics
PTGX
$896.8K
9,000 sh
$896.8K
Filed 06/01
Traded 05/29

William D. Waddill, Director — sold $370.7K of Arrowhead Pharmaceuticals ARWR · 8.7% of holdings · 10b5-1 plan | Whalegun